ARCHIVES

ODAC Member Critical Of Amgen For Price Incentives.

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | March 21, 2008

Download PDF Visit The Full Archive

Related Articles

Cytopathologists, NCI Recommend New Method For Pap Smear Reports

August 25, 1989

NCI Payline For Fiscal 1986 To Be 160 or 165

October 11, 1985

CDC: Lung Cancer Rates Drop Following Anti-Smoking Efforts

January 17, 2014

Gleevec To Prevent Recurrence Of Gastrointestinal Cancer

December 26, 2008

Wynder’s Low Fat Adjuvant Breast Cancer Study Finally Funded

October 21, 1988

Celecoxib Effective To Prevent Colon Adenomas, Study Finds

April 25, 2008